term incubation with SL-O increases the intracytosolic uptake
fold, whilst maintaining cell viability. 7, 8 If (but only if) CML cells are first permeabilised by SL-O, then ODN directed against BCR-ABL will specifically decrease BCR-ABL mRNA Introduction levels to 5-20% of control levels in both CML cell lines and in CML primary cells (Ref. 8 , and Giles RV, unpublished Chronic myeloid leukaemia (CML) is a serious neoplastic disobservations). order of the haemopoietic stem cell. Allogeneic bone marrow These encouraging molecular findings in CML cells suggest (BM) transplantation is the only currently available curative that SL-O permeabilisation might have a role in enhancing treatment option, but only a minority of patients have a suit-ODN uptake for ex vivo purging. However, the effect, toxicity able donor and are young enough to benefit from this and optimal use of SL-O in treating BM/PBSC harvests have approach.
not been studied. In the present study we examined the effect Following treatment of chronic phase CML patients with on ODN uptake and toxicity of SL-O permeabilisation in intensive chemotherapy, the blood of some patients becomes BM/PBSC harvests from CML patients. enriched for Philadelphia chromosome (Ph)-negative myeloid precursor cells.
1 These can be collected by standard leucapheresis techniques, and used to support an autologous periMaterials and methods pheral blood stem cell (PBSC) transplant.
2 The probability of achieving Ph-negative progenitors in the blood is inversely
Patients studied related to the interval between initial diagnosis and chemo-A total of 19 harvests from 15 patients were studied, all of which were from CML patients in stable first (14 patients) or ethical committee. Samples were either fresh BM harvests O (Sigma) was first pre-activated for 2 h by 5 mm dithiothreitol, checked for activity, and then frozen in aliquots at −20°C (seven cases), fresh PBSC leucoconcentrates (four cases), or previously cryopreserved harvests (five BM and three PBSC until required.
7 SL-O is rapidly inactivated by serum. In order to be effective samples) (see Table 1 ).
A Cobe Spectra (Gloucester, UK) was used in accordance in permeabilising cells, serum-free conditions are therefore required. Once ODN is loaded into cells, the SL-O induced with the manufacturer's instructions to obtain mononuclear cell fractions, either directly from the patient by leucapheresis, pores are resealed by the addition of excess serum, which inactivates SL-O. In our previous work in permeabilising CML or by processing of fresh BM harvests. The resultant leucoconcentrate was typically of around 100 ml with a red cell cell lines, we used a serum-free permeabilisation buffer containing ATP and glucose. 7, 8 However, during the course of the haematocrit of 3-5%. In the case of cryopreserved samples, 40-100 × 10 8 cells in 100 ml of autologous plasma with 10% present study it became apparent that cells permeabilised using this serum-free buffer, whilst viable in the short term, dimethyl sulphoxide (BDH, Lutterworth, UK) were first thawed rapidly, and to them was then added 60 ml of trisodium citrate did not subsequently grow well in cell culture conditions, and this also occurred in permeabilised cells which were not (Sigma, Poole, UK) and the volume made up to about 500 ml by addition of calcium and magnesium-free Dulbecco's loaded with ODN. In the later experiments of the present data, we therefore used serum-free RPMI 1640 medium (Gibco) as phosphate-buffered saline (Gibco, Paisley, UK) in 1% human albumin solution (Blood Products Laboratory, Elstree, UK) permeabilisation buffer, at a concentration of 10 7 cells per ml. Once suspended in either permeabilisation buffer, cells (DPBS-HAS). Cells were centrifuged at 200 g for 10 min, and the resuspended pellet was washed twice in DPBS-HAS with were exposed at 37°C to (1) Figure 2 gives the effect of SL-O on ODN uptake into population A (Figure 2a and b) and B (Figure 2c and d) . The SL-O directed ODN were deliberately not used, since these will down-regulate BCR-ABL mRNA, 8 and could potentially proconcentration for both populations was 5 units per 10 6 cells; this concentration was shown in preliminary experiments to duce inhibitory effects on cell growth, 10 which could confound a putative toxic effect of SL-O permeabilisation. Instead, be optimal for permabilising population B. SL-O permeabilisation increased ODN uptake in both populations, and ODN we used inactive 15-mer ODN targeted to MYC, linked entirely by methylphosphonate linkages apart from a single uptake at a given SL-O concentration was considerably greater in population B. The same degree and pattern of central phosphodiester internucleoside linkage, and which we had shown in previous work to be without biological effect uptake was observed irrespective of ODN structure studied. For optimal ODN uptake, population A consistently required in all cell lines (including CML cell lines) tested. 8 greater concentrations of SL-O. At the optimal SL-O concentration for each population, ODN uptake by population A was consistently greater than that of population B (data not CFU-GM assays shown). SL-O levels which were optimal for the permeabilisation of population A were sufficient to kill the majority of CFU-GM assays were carried out by adding 2.5 ml of Iscove's medium, 0.5 ml of bladder carcinoma cell line 5637 concells in population B. Since population B was consistently at least twice as great as population A, if the optimal SL-O conditioned medium, 1 ml of FCS and 0.5ml of 3.3% agar to 0.5 ml aliquots of resealed cells. These were incubated at 37°C centration was determined on the whole 'mononuclear' cell fraction, ODN uptake into the CD34-positive cells in popuin 5% CO 2 for 10 days. The numbers of resultant CFU-GM colonies were expressed per 10 5 plated cells. lation A was suboptimal. In summary, on mononuclear cell fractions which were not selected for CD34-positive cells, unpredictable and variable patterns of ODN uptake were seen, because of the considerable heterogeneity in the makeResults up of the mononuclear cell fraction from patient to patient in CML. All further work was therefore carried out on CD34-SLO-facilitated ODN uptake on unselected harvests selected cells. Initial experiments were carried out on 10 fresh CML harvests, which were not selected for CD34-positive cells. All harvests were processed on the Cobe Spectra before study, to prepare Effects of permeabilisation buffer cell fractions enriched for mononuclear cells. Figure 1 shows flow cytometry results representative of mononuclear fractions Figure 3 compares the effect of serum-free ATP and glucosecontaining permeabilisation buffer (SFPB) and serum-free from each of harvests 1-10 in Table 1 . Forward and right angle light scattering properties consistently defined two dis-RPMI medium, on ODN uptake and viability of a representative CD34-selected harvest. Figure 3a shows the proportion of tinct cell populations, labelled A and B in Figure 1 . CD34-positive cells were consistently found in population A, where permeabilised and viable cells in each buffer; Figure 3b gives the proportion of non-viable cells. For a given SL-O concentration, a greater proportion of cells permeabilised by SFPB were non-viable. The concentration of SL-O giving maximal permeabilised viable cells was lower for the SFPB than for RPMI, and the proportion of permeabilised cells was greater in RPMI buffer. For RPMI permeabilised cells, there was a greater 'window' between the SL-O concentration giving maximal permeabilised viable cells and the SL-O concentration beyond which the proportion of non-viable cells begins to climb steeply. For SFPB permeabilised cells, this window is narrower, making it more difficult in practice to get reproducible ODN uptake into CD34-selected samples without undue direct toxicity.
SL-O facilitated ODN uptake into CD34-selected harvests
CD34-positive cells were prepared from nine CML harvests. The purity of the CD34-positive fractions is given in Table 2 . These samples were used to study ODN uptake into CD34-positive cells permeabilised by SL-O in RPMI buffer. Owing to limitations on the numbers of CD34-positive cells available Table 2 gives the optimal SL-O concentration positive population was studied by flow cytometry, the proportion of permeabilised and viable cells was 56% (data not (defined as that concentration giving the greatest proportion of permeabilised viable cells, with the least proportion of nonshown). This suggests that a significant number of the nonpermeabilising cells in this patient were the contaminating viable cells) and its effects for the remaining harvests studied.
CD34-negative cells.
Comparison of SL-O-facilitated ODN uptake in PBSC and BM harvests Effect of SL-O and ODN on CFU-GM growth
After SL-O permeabilisation and ODN uptake studies, cells The data of Table 2 suggest that after SL-O permeabilisation of CD34-selected fractions, PBSC harvests tend to have a greater were plated for CFU-GM. Figure 5 gives representative results
Figure 4
Effect of increasing SL-O concentration on ODN uptake and cell viability.
Figure 3
Comparison of serum-free permeabilisation buffer (SFPB) and serum-free RPMI 1640 (RPMI) on (a) the proportion of permeabilised and viable cells, and (b) the proportion of non-viable cells, at various SL-O concentrations (units per 10 6 cells per 100 l). O increases above the optimal value of 6 units per 10 6 cells, there is a progressive decrease of CFU-GM growth to less than 10% of control values at SL-O concentrations of 10 or more units per 10 6 cells. This is mirrored by a corresponding rise Discussion in the proportion of non-viable cells. SL-O does not therefore appear significantly toxic to CFU-GM at concentrations
We have previously reported the effect of ODN on CML cells. ODN complementary to nine bases either side of the BCRoptimal for ODN uptake. 15, 16 No unexpected toxicity has been observed, but neither trial used any means to increase ODN effects, 5, 10, 11 which might increase their toxicity on nonleukaemic cells. In CML cell lines, we previously reported that uptake into the cytosol. Without initial cell permeabilisation, ODN access to the cytosol is very poor, 3 even in the presence the most efficient and specific ODN structure was a chimaeric 18-mer, in which the central 10 nucleosides are held together of high extracellular concentrations of ODN. It is likely that initial cell permeabilisation will be required to demonstrate by nine phosphodiester linkages, with the 5′ and 3′ flanking four nucleosides held together by methylphosphonate linkthe full potential of ex vivo ODN purging. The present data suggest that SL-O may be used in the clinical setting, to ages. This chimaeric '494' structure achieved a superior sequence-specific antisense effect to other chimaeric ODN enhance ODN uptake into haemopoietic cell harvests, prior to autologous transplantation. structures ('656' and '737') , or all-phosphodiester or all-PS linked ODN. 8 In subsequent work, we have confirmed that chimaeric '494' ODN directed against the b2a2 junction will also significantly down-regulate BCR-ABL mRNA levels in Acknowledgements b2a2 transcript containing CML primary cells, whilst no effect was seen with b3a2 directed ODN, or recently synthesised b2a2 and b3a2 directed chimeric '494'
